These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 34946207)

  • 1. Special Issue: From Host-Pathogen Interaction to Host-Directed Therapies.
    Gomes MS; Pereira L
    Microorganisms; 2021 Dec; 9(12):. PubMed ID: 34946207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative host-pathogen protein-protein interaction analysis of recent coronavirus outbreaks and important host targets identification.
    Khan AA; Khan Z
    Brief Bioinform; 2021 Mar; 22(2):1206-1214. PubMed ID: 32914167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host directed therapies: COVID-19 and beyond.
    Tripathi D; Sodani M; Gupta PK; Kulkarni S
    Curr Res Pharmacol Drug Discov; 2021; 2():100058. PubMed ID: 34870156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alignment of virus-host protein-protein interaction networks by integer linear programming: SARS-CoV-2.
    Llabrés M; Valiente G
    PLoS One; 2020; 15(12):e0236304. PubMed ID: 33284827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2: Pathogenic Mechanisms and Host Immune Response.
    Yasmin H; Saha S; Butt MT; Modi RK; George AJT; Kishore U
    Adv Exp Med Biol; 2021; 1313():99-134. PubMed ID: 34661893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic: An Executive Document by the Board of the Italian Society of Cardiovascular Prevention.
    Volpe M; Battistoni A; ; Bellotti P; Bellone S; Bertolotti M; Biffi A; Consoli A; Corsini A; Desideri G; Ferri C; Modena MG; Nati G; Pirro M; Rubattu S; Tocci G; Trimarco B; Volpe R; de Kreutzenberg SV
    High Blood Press Cardiovasc Prev; 2020 Oct; 27(5):373-377. PubMed ID: 32734561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host-directed therapies to combat tuberculosis and associated non-communicable diseases.
    Baindara P
    Microb Pathog; 2019 May; 130():156-168. PubMed ID: 30876870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microfluidic Organs-on-a-Chip for Modeling Human Infectious Diseases.
    Wang Y; Wang P; Qin J
    Acc Chem Res; 2021 Sep; 54(18):3550-3562. PubMed ID: 34459199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and emerging infectious diseases: The society is still unprepared for the next pandemic.
    Frutos R; Gavotte L; Serra-Cobo J; Chen T; Devaux C
    Environ Res; 2021 Nov; 202():111676. PubMed ID: 34252435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Entry, egress and vertical transmission of SARS-CoV-2.
    Zhang H; Zhang H
    J Mol Cell Biol; 2021 Jul; 13(3):168-174. PubMed ID: 33677567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shedding Light on the Effect of Natural Anti-Herpesvirus Alkaloids on SARS-CoV-2: A Treatment Option for COVID-19.
    Hassan STS
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32340120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
    Kim CH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host.
    Lite C; Ahmed SSSJ; Juliet M; Freddy AJ
    Pathog Dis; 2021 Feb; 79(2):. PubMed ID: 33469663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host-directed therapies: a potential solution to combat COVID-19.
    Baindara P; Agrawal S; Mandal SM
    Expert Opin Biol Ther; 2020 Oct; 20(10):1117-1120. PubMed ID: 32783643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
    Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique fibrinogen-binding motifs in the nucleocapsid phosphoprotein of SARS CoV-2: Potential implications in host-pathogen interactions.
    Sangith N
    Med Hypotheses; 2020 Nov; 144():110030. PubMed ID: 32758876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of host epigenome by coronavirus infections and developing treatment modalities for COVID-19 beyond genetics.
    Rabaan AA; Al Mutair A; Alhumaid S; Al Alawi Z; Al Mohaini M; Alsalman AJ; Fawzy M; Al-Tawfiq JA; Almahmoud S; Alfouzan W; Bilal M; Dhawan M; Mohapatra RK; Tiwari R; Khan Z; Mitra S; Emran TB; Dhama K
    Eur Rev Med Pharmacol Sci; 2021 Oct; 25(19):5947-5964. PubMed ID: 34661254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplex Biosensing for Simultaneous Detection of Mutations in SARS-CoV-2.
    Xi H; Jiang H; Juhas M; Zhang Y
    ACS Omega; 2021 Oct; 6(40):25846-25859. PubMed ID: 34632242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell Biology of Viral Infections.
    Lozach PY
    Cells; 2020 Nov; 9(11):. PubMed ID: 33171736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.